Paul Wibbels, MD
Internal Medicine · Hastings, NENPI 1336142900
Payments from drug & device makers
Across 591 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$1K
- Novo Nordisk$984
- Lilly USA, LLC$928
- Pfizer$661
- Amgen$591
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $1,285 |
| AbbVie(2 entities) | 69 | $1,055 |
| Novo Nordisk | 70 | $984 |
| Lilly USA, LLC | 64 | $928 |
| Pfizer | 84 | $661 |
| Amgen | 47 | $591 |
| Boehringer Ingelheim | 50 | $564 |
| Aimmune Therapeutics, Inc. | 4 | $353 |
| Johnson & Johnson | 15 | $313 |
| GSK | 33 | $301 |
| Sanofi-aventis U.S. LLC | 21 | $287 |
| Novartis | 20 | $284 |
| Exact Sciences | 20 | $263 |
| Astellas Pharma US Inc | 13 | $232 |
| Bayer | 13 | $187 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $177 |
| Mylan Specialty L.p. | 6 | $87 |
| Merck | 6 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $59 |
| Dexcom, Inc. | 4 | $59 |
| Grifols USA, LLC | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 2 | $28 |
| Genentech USA, Inc. | 2 | $27 |
| Neurocrine Biosciences, Inc. | 2 | $26 |
| Biogen | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$9,085 in reported general payments places this provider in the 90th percentile of 570 internal medicine providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Hastings
- Justin WenburgHastings$10K
- Douglas HentzenHastings$9K
- Matthew StrittHastings$6K
- Michelle SeizysHastings$5K
- Richard FrenchHastings$4K
- Scott RasmussenLincoln$38.1M
- Charles HarperNorfolk$31.1M
- Robert SchwabBoys Town$9.2M
- Michael DunnOmaha$7.9M
- Alexander RyanLincoln$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.